---
title: Customizing the Exome
description: In this webinar, Ben Niu, Ph.D., Scientist at MedImmune, will share how he created a vendor-neutral MAM workflow to monitor multiple molecule attributes, perform quantitation and generate reports to support drug development in multiple studies.
image: https://go.technologynetworks.com/hubfs/STARLIMS-990x200-1.png
---

![Customizing_the_Exome_990x200.png](https://go.technologynetworks.com/hs-fs/hubfs/Customizing_the_Exome_990x200.png?width=989&name=Customizing_the_Exome_990x200.png "Customizing_the_Exome_990x200.png")

# Overview

Title:

Some additional information in one line

Duration:

Some additional information in one line

Avaliable On Demand

# Register Now

*Already registered?*  
[Access the webinar here »](https://globalmeet.webcasts.com/starthere.jsp?ei=1218226&tp_key=6f48db47a1)

You must have Javascript and Cookies enabled to access this webcast.

# Webinar Summary

The introduction of exome analysis provides the opportunity to improve more findings compared to traditional genetic testing approaches and fixed panel-based genomic analyses. Large studies of many families using trio exomes and a genotype first approach have been incredibly powerful tools for gene discovery and identification of pathogenic variants in rare Mendelian disorders. Proband only exomes, however, require different methods of variant filtering which typically involve prioritisation of genes and/or variants based on phenotype.

 Eager to realize the benefits of exome testing and streamline laboratory workflows, we evaluated a number of enrichment products before developing a 17Mb SureSelect custom constitutional panel for use in our laboratory.

Combined with an internet browser based system for the referral of cases, which incorporates an algorithm for dynamic gene panel selection using the Human Phenotype Ontology (HPO), we provide an affordable proband only exome service which maximises detection rate and simultaneously minimizes wasted sequencing capacity while avoiding the requirement for continuous redesign and validation of disease-specific gene panels following new evidence.

# Speaker Information:

![Ronnie Wright](https://go.technologynetworks.com/hs-fs/hubfs/Technology%20Networks/Landing%20Pages/TN%20Webinars/Agilent%2028th%20November%202018%20/Ronnie.png?width=100&name=Ronnie.png "Ronnie Wright")

Ronnie Wright  
Principal Clinical Scientist,   
Manchester Centre for Genomic Medicine

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our [Privacy Policy](https://www.technologynetworks.com/tn/privacy)

Technology Networks Limited

Woodview | Bull Lane Industrial Estate | Sudbury | C010 0FD | UK

[Email: privacy@technologynetworks.com](mailto:privacy@technologynetworks.com?Subject=Privacy)

 

© 2018 Technology Networks

All rights reserved

[Privacy Policy & Disclaimer](https://www.technologynetworks.com/tn/privacy)